We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: PayPal, Netflix, Sanofi, Caterpillar and The TJX Companies
Read MoreHide Full Article
For Immediate Release
Chicago, IL – August 23, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: PayPal Holdings, Inc. (PYPL - Free Report) , Netflix, Inc. (NFLX - Free Report) , Sanofi (SNY - Free Report) , Caterpillar Inc. (CAT - Free Report) and The TJX Companies, Inc. (TJX - Free Report) .
Here are highlights from Friday’s Analyst Blog:
Top Research Reports for PayPal, Netflix and Sanofi
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including PayPal, Netflix and Sanofi. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Shares of PayPal have outperformed the Zacks Internet Software industry over the past year (+37.5% vs. +14.4%). The Zacks analyst believes that PayPal is poised to benefit from its robust two-sided platform, safety and simplicity of transactions and strategic partnerships.
Strong performance by Venmo and merchant services has been contributing well to the TPV growth. Boom in digital payment due to the ongoing pandemic, is another factor supporting growth. Solid momentum across peer to peer and PayPal Checkout experiences is a tailwind. Intensifying competition in the digital payment market, however, remains a threat to the company’s market position.
Netflix shares have gained +2.5% over the last six months against the Zacks Broadcast Radio and Television industry’s loss of -6.8%. The Zacks analyst believes that the company stands to benefit from a growing subscriber base, focus on originals across genres and languages, rapid international expansion as well as partnerships with telcos.
The launch of low-priced mobile plans is likely to expand Netflix’s subscriber base in Asia Pacific. A solid content slate and resumption of production is expected to further aid Netflix’s prospects in the third quarter of 2021. Rising competition, however, from Apple, Amazon, HBO Max, Disney+ and Peacock is a major headwind.
Shares of Sanofi have gained +12% in the year to date period against the Zacks Large Cap Pharmaceuticals industry’s gain of +22%. The company is, however, gaining momentum as is evident from its Q2 earnings and sales beat. The Zacks analyst believes that Dupixent has become the key top-line driver for the company.
Sanofi has a leading vaccine operation as well as a strong R&D pipeline. Several data read-outs are expected till 2022. It has also launched several new drugs in the past couple of years and is expanding its pipeline through M&A deals. Weakness in the Diabetes units and generic competition to its key drugs remain major headwinds though.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: PayPal, Netflix, Sanofi, Caterpillar and The TJX Companies
For Immediate Release
Chicago, IL – August 23, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: PayPal Holdings, Inc. (PYPL - Free Report) , Netflix, Inc. (NFLX - Free Report) , Sanofi (SNY - Free Report) , Caterpillar Inc. (CAT - Free Report) and The TJX Companies, Inc. (TJX - Free Report) .
Here are highlights from Friday’s Analyst Blog:
Top Research Reports for PayPal, Netflix and Sanofi
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including PayPal, Netflix and Sanofi. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Shares of PayPal have outperformed the Zacks Internet Software industry over the past year (+37.5% vs. +14.4%). The Zacks analyst believes that PayPal is poised to benefit from its robust two-sided platform, safety and simplicity of transactions and strategic partnerships.
Strong performance by Venmo and merchant services has been contributing well to the TPV growth. Boom in digital payment due to the ongoing pandemic, is another factor supporting growth. Solid momentum across peer to peer and PayPal Checkout experiences is a tailwind. Intensifying competition in the digital payment market, however, remains a threat to the company’s market position.
(You can read the full research report on PayPal here >>>)
Netflix shares have gained +2.5% over the last six months against the Zacks Broadcast Radio and Television industry’s loss of -6.8%. The Zacks analyst believes that the company stands to benefit from a growing subscriber base, focus on originals across genres and languages, rapid international expansion as well as partnerships with telcos.
The launch of low-priced mobile plans is likely to expand Netflix’s subscriber base in Asia Pacific. A solid content slate and resumption of production is expected to further aid Netflix’s prospects in the third quarter of 2021. Rising competition, however, from Apple, Amazon, HBO Max, Disney+ and Peacock is a major headwind.
(You can read the full research report on Netflix here >>>)
Shares of Sanofi have gained +12% in the year to date period against the Zacks Large Cap Pharmaceuticals industry’s gain of +22%. The company is, however, gaining momentum as is evident from its Q2 earnings and sales beat. The Zacks analyst believes that Dupixent has become the key top-line driver for the company.
Sanofi has a leading vaccine operation as well as a strong R&D pipeline. Several data read-outs are expected till 2022. It has also launched several new drugs in the past couple of years and is expanding its pipeline through M&A deals. Weakness in the Diabetes units and generic competition to its key drugs remain major headwinds though.
(You can read the full research report on Sanofi here >>>)
Other noteworthy reports we are featuring today include Caterpillar and The TJX Companies.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.